Quest Diagnostics Inc Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
Quest Diagnostics Inc (DGX) reported Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 · last filed 2023-02-21
- Quest Diagnostics Inc change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2022 was $0.00.
- Quest Diagnostics Inc change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2021 was $0.00.
- Quest Diagnostics Inc change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2020 was -$68.00M.
| Period end | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-21 |
| 2020-12-31 | -$68.00M 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |